The future for UK regulation of medicines, medical devices and clinical trials

16/07/2020

Stakeholders in health research and policymakers will discuss:

  • Priorities for regulation and the role of the MHRA;

  • Meeting the challenge of regulating and developing medicines during the Covid-19 Pandemic;

  • Stakeholder priorities for medicine regulation - safety, research integrity and innovation:

  • The future for collaboration with the EU, and the UK’s relationship with the EMA ;

  • Using technology to tackle irresponsible medical ads - partnership with online platforms and statutory enforcement partners; and

  • Key issues for ensuring quality in clinical trials and the medicine approval process - research integrity, public trust and workforce development.

London, UK (online) 

More information

Ask for a Free trial and get access to the latest stories

Our coverage includes:
  • Health Care
  • Market Access
  • HTA – policies & practices
  • European medicine regulations
  • Drug safety issues
  • Pricing & Reimbursement
  • International medicines agencies

If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.

REQUEST

an initial 10 day temporary access of APM Health Europe.